sRAGE was positively correlated with prohepcidin and the indicators for the assessment of autoimmune status (RF and anti-CCP antibodies), bone resorption (sRANKL), and inflammation (CRP and IL-6) only in the ACD subgroup (sTfR-F index < 1.5). The gene discussed is CRP; the disease is granular corneal dystrophy type II.